Skip to main content
Earl Glusac, MD, Pathology, New Haven, CT

EarlJGlusacMD

Pathology New Haven, CT

Dermatopathology, Anatomic Pathology, Clinical Pathology

Professor, Pathology, Yale University School of Medicine

Dr. Glusac is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Glusac's full profile

Already have an account?

  • Office

    800 Howard Ave
    Yale Physicians Building
    New Haven, CT 06519
    Phone+1 203-785-2140
    Fax+1 203-785-6414

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Dermatopathology, 1993 - 1994
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Pathology-Anatomic and Clinical, 1989 - 1993
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Psychiatry, 1988 - 1989
  • Lafayette Clinic
    Lafayette ClinicInternship, Transitional Year, 1987 - 1988
  • Michigan State University College of Human Medicine
    Michigan State University College of Human MedicineClass of 1987

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - 2025
  • CT State Medical License
    CT State Medical License 1994 - 2025
  • American Board of Pathology Anatomic Pathology & Clinical Pathology
  • American Board of Pathology Dermatopathology

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2014

Publications & Presentations

PubMed

Lectures

  • Approach to Pigmented Lesions 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Press Mentions

  • Melanoma Is Overdiagnosed at ‘Alarming’ Rates. Here’s What to Know
    Melanoma Is Overdiagnosed at ‘Alarming’ Rates. Here’s What to KnowFebruary 15th, 2024